Question 1

Can this protocol replace my ulcerative colitis medication?

Accepted Answer

No. Ulcerative colitis is a serious medical condition that requires professional management, and every strategy described here is intended to sit alongside gastroenterologist-prescribed treatment such as mesalamine or 5-ASA, immunomodulators, or biologics. The evidence for these adjuncts is strongest when they are added to standard therapy rather than substituted for it, and prescribed medications should never be stopped or reduced without medical guidance.

Question 2

Why does the protocol say to avoid prebiotics during a flare?

Accepted Answer

Timing matters with fermentable fibre. During active UC inflammation, prebiotic fibre can worsen bloating, gas, cramping and diarrhea. The protocol introduces prebiotics only once remission is confirmed and a gastroenterologist has verified that inflammatory markers such as fecal calprotectin and CRP are controlled, starting at very small doses and increasing slowly over four to six weeks.

Question 3

What makes VSL#3 different from an ordinary probiotic?

Accepted Answer

The VSL#3 or De Simone formulation combines eight strains at an ultra-high dose of 450 to 900 billion CFU per day: L. acidophilus, L. plantarum, L. paracasei, L. delbrueckii subsp. bulgaricus, B. longum, B. breve, B. infantis, and Streptococcus thermophilus. It is the most studied probiotic formulation in UC, with consistent positive results across RCTs and meta-analyses, and the ultra-high dose appears to be central to that result.

Question 4

Is any probiotic considered an alternative to mesalazine for maintenance?

Accepted Answer

E. coli Nissle 1917 is the only probiotic strain recognised by AGA and ECCO guidelines as a legitimate maintenance alternative to standard 5-ASA therapy, based on a double-blind, double-dummy RCT that found it non-inferior to mesalazine 1.5g per day for maintaining remission. It is described as particularly useful for people who are intolerant to mesalazine or who wish to reduce medication burden during stable remission, and that decision belongs with a gastroenterologist.

Question 5

Which number matters most for tracking progress?

Accepted Answer

Fecal calprotectin. It directly reflects intestinal inflammation and is more sensitive than symptoms alone, because many people with UC feel fine while subclinical inflammation continues to damage the colon. A target below 150 mcg/g indicates remission, below 50 is ideal, and a rising value even without symptoms is worth raising with a gastroenterologist.

Question 6

Is fecal microbiota transplantation something to try independently?

Accepted Answer

No. FMT is an emerging clinical treatment performed under medical supervision at specialised centres, not a do-it-yourself intervention. A 2025 meta-analysis of 14 RCTs found it significantly improved combined clinical and endoscopic remission, and it may be appropriate for moderate-to-severe UC that has not responded adequately to standard therapies, but the conversation starts with a gastroenterologist.

Ulcerative Colitis Microbiome Protocol: Evidence-Based Plan